Mitsubishi Chemical Group Corporation
Fiscal Year Ending March 2026 Q3 Financial Results Briefing
Quarterly net income attributable to owners of parent for the third quarter of the fiscal year ending March 2026 increased 77% YoY to ¥105.4 billion. Full-year net income forecast was sharply revised down from ¥125.0 billion to ¥47.0 billion.
Key Figures
- Quarterly Net Income Attributable to Owners of Parent: ¥105.4 billion (77% increase YoY)
- Full-Year Net Income Attributable to Owners of Parent Forecast: ¥47.0 billion (62% decrease from previous forecast ¥125.0 billion)
- Revenue: ¥2,737.3 billion (8% decrease YoY)
AI要約
Overview of Performance
For the third quarter of the fiscal year ending March 2026, revenue amounted to ¥2,737.3 billion (8% decrease YoY), and core operating income was ¥185.6 billion (2% decrease YoY). The Chemicals segment faced a 22% profit decline YoY due to a challenging market environment, while the Industrial Gases segment performed steadily, limiting the overall group's profit decline. Despite recording extraordinary losses, the quarterly net income attributable to owners of parent rose 77% YoY to ¥105.4 billion, reflecting gains from the transfer of Tanabe Mitsubishi Pharma.
Revisions to Full-Year Earnings Forecast and Future Outlook
Taking into account the recording of extraordinary losses related to the exit from the Coke & Carbon Materials business, the full-year net income attributable to owners of parent forecast was sharply revised down from ¥125.0 billion to ¥47.0 billion. However, the core operating income forecast remains unchanged at ¥250.0 billion. The dividend forecast is maintained at ¥16 per share at year-end and ¥32 annually. Based on the 2029 Medium-Term Management Plan, the company will accelerate business portfolio optimization and disciplined operations to reform its portfolio and improve profitability.
